Skip to main content
Premium Trial:

Request an Annual Quote

Gretchen Brodnicki, David King, Shantanu Basu

Gretchen Brodnicki has been named dean for faculty and research integrity at Harvard Medical School.
Brodnicki is currently director of research compliance for the Partners HealthCare System, and works with faculty and administration at four affiliated teaching hospitals, Brigham and Women’s, Massachusetts General, McLean, and Spaulding.
Before joining Partners, she served as director of research compliance for Beth Israel Deaconess Medical Center. Prior to this, she practiced law privately in the areas of civil litigation and health care, representing clients in intellectual property disputes as well as in corporate, regulatory, and transactional matters with an emphasis on fraud prevention, practice integration, and risk management.
Brodnicki earned a BS in business administration from Gannon University and a JD from Suffolk University Law School in Boston.

Mid-Atlantic region venture capital firm Quaker BioVentures said last week that David King has joined the company as a venture partner.
King has previously served as CEO of three venture-backed life science companies, including BioRexis Pharmaceuticals, which was acquired by Pfizer in 2007, and Principia Pharmaceuticals, which was acquired by Human Genome Sciences. He also served as president of Delsys Pharamceutical, now Elan.
King also previously was a director of Cephalon, 3-Dimensional Pharmaceuticals, and Morphotek. Currently, he serves as chairman of Xencor.

Shantanu Basu has joined Mintz, Levin, Cohn, Ferris, Glovsky and Popeo in the law firm’s West Coast intellectual property practice in Palo Alto, Calif.
Basu represents companies in biotechnology, pharmaceutical, biochip, and related industries. He joins Mintz Levin from Morrison & Foerster. He holds a PhD in molecular biology from Albert Einstein College of Medicine and a JD from Fordham University School of Law.

The Scan

US Booster Eligibility Decision

The US CDC director recommends that people at high risk of developing COVID-19 due to their jobs also be eligible for COVID-19 boosters, in addition to those 65 years old and older or with underlying medical conditions.

Arizona Bill Before Judge

The Arizona Daily Star reports that a judge weighing whether a new Arizona law restricting abortion due to genetic conditions is a ban or a restriction.

Additional Genes

Wales is rolling out new genetic testing service for cancer patients, according to BBC News.

Science Papers Examine State of Human Genomic Research, Single-Cell Protein Quantification

In Science this week: a number of editorials and policy reports discuss advances in human genomic research, and more.